Filip Surmont, MD

Articles by Filip Surmont, MD

Silent (R)evolution in Medical Affairs Through the Power of Partnerships and Collaborations

ByAlexander Bedenkov, MD, PhD,Andrey Ipatov, MD,Filip Surmont, MD,Carmen Moreno,Maarten Beekman, MD,Ryan Bate

October 11th 2019

Pharmaceutical Executive

A look at how Medical Affairs is transitioning to a new and fundamental strategic role within pharma and ways MA can step up to own this role within a pharma company, particularly within emerging markets.

Latest Updated Articles

Silent (R)evolution in Medical Affairs Through the Power of Partnerships and Collaborations
October 11th 2019

Trending on PharmExec

The Significance of FDA’s First Warning Letter for Inappropriate Use of AI

Jazz Pharmaceuticals to Acquire Actio Biosciences for $1.32 Billion

Generating Commercial Evidence from Agentic Field and Brand Engagement to Accelerate Launch Performance

M&A Roundup: Novo Nordisk Enters AI Drug Discovery Partnership with Amazon, Innate Pharma Partners with Sobi, Innovent Enters Commercialization Agreement with Daiichi Sankyo